Sanofi is preparing a phase 3 programme for asthma candidate amlitelimab, despite mixed data in a phase 2 trial.

The NE-U22V MicroAir, the world’s smallest nebulizer utilizing Vibrating Mesh Technology (V.M.T.), efficiently delivers solution medications for patients suffering from asthma, COPD or other ...

The Inspiration 626 was designed with compliance in mind. Multi-media patient education support materials and built-in conveniences make this efficient nebulizer system the ideal choice for ...

GSK's long-acting drug antibody for severe asthma, depemokimab, cut the rate of attacks by 54% in phase 3 trials presented at ERS.

Find allergy and asthma news articles, videos, blogs, books, Continuing Medical Education (CME), meeting coverage, and journal articles.